ProCE Banner Activity

Managing Adverse Events With New Treatments Targeting EGFR Exon 20 Insertion Mutations in Patients With Advanced NSCLC

Download this reference guide for key points on patient counseling, monitoring, and managing toxicities associated with approved therapies targeting EGFR exon 20 insertions in patients with NSCLC.

Released: April 28, 2022

Expiration: April 27, 2023

No longer available for credit.


Provided by

Provided by Clinical Care Options, LLC
ProCE Banner


Supported by an educational grant from

Takeda Pharm USA